Neese v. Becerra

CourtDistrict Court, N.D. Texas
DecidedApril 26, 2022
Docket2:21-cv-00163
StatusUnknown

This text of Neese v. Becerra (Neese v. Becerra) is published on Counsel Stack Legal Research, covering District Court, N.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Neese v. Becerra, (N.D. Tex. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT | Nog? Distr □□ FOR THE NORTHERN DISTRICT OF TEXAS DISTRI: □□ RY AMARILLO DIVISION | □□ □□□□□ APR 9 p SUSAN NEESE et al., § | CLERK = 2022 | □ § | Ry err Te □□□□□ | Plaintiffs, § Deputy □ § v. § 2:21-CV-163-Z § XAVIER BECERRA, in his official § capacity as the Secretary of the United § States Department of Health and Human § Services, ef al., § § Defendants. § OPINION AND ORDER Justice Alito predicted this day would come: “Although the Court does not want to think about the consequences of [Bostock v. Clayton County], we will not be able to avoid those issues for long. The entire Federal Judiciary will be mired for years in disputes about the reach of the Court’s reasoning.” 140 S. Ct. 1731, 1783 (2020) (Alito, J., dissenting). With similar prescience, Justice Kavanaugh identified the category of controversy at issue here: “Healthcare benefits may emerge as an intense battleground under the Court’s holding.” /d. at 1781 (Kavanaugh, J., dissenting) (collecting cases) (emphasis added). With poetic force, Justice Alito likened Bostock to a “pirate ship” sailing under a “textualist flag,” but representing “a theory of statutory interpretation that Justice Scalia excoriated — the theory that courts should ‘update’ old statutes so that they better reflect the current values of society.” Jd. at 1755-56 (Alito, J., dissenting). Today, the metaphorical “pirate ship” arrives at an inland port: the Amarillo Division of the Northern District of Texas.

Before the Court is Defendants’ Motion to Dismiss Plaintiffs’ First Amended Complaint (“Motion”) (ECF No. 16), filed on December 14, 2021.! In support of two claims, Plaintiffs argue that Section 1557 of the Affordable Care Act and Bostock “do not prohibit discrimination on account of sexual orientation and gender identity” if the healthcare providers “would have acted in the same manner had the patient had been a member of the opposite biological sex.” ECF No. 11 at 10. Having considered the pleadings, Bostock, and relevant cases, the Court DENIES Defendants’ Motion. BACKGROUND Section 1557 of the Affordable Care Act prohibits discrimination on the basis of “sex.” See 42 U.S.C. § 18116(a) (incorporating into Section 1557, inter alia, Title [X’s prohibition of discrimination “on the basis of sex,” 20 U.S.C. § 1681(a)). In Bostock, the Supreme Court held that Title VII’s “because of... sex” terminology should be read to prohibit “sexual orientation” and “gender identity” (combined, “SOGI”) discrimination. See generally 140 S. Ct. 1731. Citing Bostock, the Department of Health and Human Services (“HHS”) announced it would “interpret and enforce” Section 1557’s prohibition on discrimination “on the basis of sex” to include SOGI. See generally Department of Health and Human Services, Notification of Interpretation and Enforcement of Section 1557 of the Affordable Care Act and Title LX of the Education Amendments of 1972, 86 Fed. Reg. 27,984 (May 25, 2021) (“Notification”).

' Plaintiffs include Dr. Susan Neese, Dr. James Hurly, and Dr. Jeffrey Barke. Defendants include Xavier Becerra, in his official capacity as Secretary of Health and Human Services, and the United States. 2 In the First Amended Complaint (ECF. No. 11), Defendants’ Motion (ECF No. 16), and Plaintiffs’ Brief in Opposition (ECF. No. 17), Plaintiffs and Defendants intermittently use the terms “homosexual,” “bisexual,” and “transgender” to refer to the disputed categories “sexual orientation” and “gender identity” referenced in Bostock and the Notification. Because the relevant jurisprudence, statutes, regulations, and administrative issuances assume the former is included in the latter, this Court will refer to “SOGI” as collective of all aforementioned categories — unless particularity is necessary for the Court’s analysis.

Plaintiffs — Texas and California-based physicians — allege Defendants misread Bostock and that healthcare providers may continue to discriminate on the basis of SOGI, “so long as one does not engage in ‘sex’ discrimination when doing so.” ECF No. 11 at 5. Specifically, Plaintiffs aver that neither Section 1557 nor Bostock prohibit such discrimination, “as long as they would have acted in the exact same manner if the patient had been a member of the opposite biological sex.” ECF No. 17 at 16. Plaintiffs “object only to the Secretary’s claim that Bostock defined ‘sex’ discrimination to encompass all forms of discrimination on the basis of sexual orientation or gender identity.” Jd. Plaintiffs state they “fully intend to comply with Bostock and its interpretation of ‘sex.’” Id. Plaintiffs have discriminated on the basis of sex in their medical practices, and each receives federal money subject to Section 1557. See generally ECF No. 11. Dr. Neese “has treated patients suffering from gender dysphoria in the past and has on occasion prescribed hormone therapy for them.” /d. at 5. But Dr. Neese “does not believe that hormone therapy or sex-change operations are medically appropriate for everyone who asks for them, even if those individuals are suffering from gender dysphoria, and she will on occasion decline to prescribe hormone therapy or provide referrals for sex-change operations.” /d. at 6. “Dr. Neese is categorically unwilling to prescribe hormone therapy to minors who are seeking to transition, and she is equally unwilling to provide referrals to minors seeking a sex-change operation.” Jd. She “believes that it is unethical to provide ‘gender affirming’ care to transgender patients in situations where a patient’s denial of biological realities will endanger their life or safety.” Jd. Plaintiffs allege “Dr. Neese has treated many transgender patients . . . in the past, and she expects to continue doing so in the future.” Jd. Dr. Neese claims she “is likely to encounter minor transgender patients who will request hormone therapy and referrals for sex-change operations that

she is unwilling to provide, as well as adult transgender patients who will deny or dispute their need for preventive care that corresponds to their biological sex, and she intends to provide care to these individuals in a manner consistent with her ethical beliefs.” Jd. Dr. Hurly “recognizes that some biological men may identify as women (and vice versa).” Id. In his practice, Dr. Hurly “has encountered situations . .. when he must insist that a patient acknowledge his biological sex rather than the gender identity that he asserts.” /d. at 7. Plaintiffs provide an example: Dr. Hurly “once diagnosed a biological male patient with prostate cancer, but the patient refused to accept Dr. Hurly’s diagnosis because he identified as a woman and insisted that he could not have a prostate.” Jd. Dr. Hurly “explain[ed] to this patient that he was indeed a biological man with a prostate, and that he needed to seek urgent medical treatment for his prostate cancer.” /d. Plaintiffs claim “Dr. Hurly has treated transgender patients in the past, and he expects to continue doing so in the future.” /d. Plaintiffs further allege: “Dr. Hurly is likely to encounter transgender patients who will deny or dispute their need for health care that corresponds to their biological sex, and he intends to provide care to these individuals in a manner consistent with his ethical beliefs.” Jd. The last Plaintiff, Dr. Barke, “is unwilling to prescribe hormone therapy to minors who are seeking to transition, and he is unwilling to provide referrals to minors seeking a sex-change operation.” Jd. He “believes that it is unethical to provide ‘gender affirming’ care to transgender patients in situations where a patient’s denial of biological realities will endanger their life or safety.” Jd. at 8. “Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Shields v. Norton
289 F.3d 832 (Fifth Circuit, 2002)
Abbott Laboratories v. Gardner
387 U.S. 136 (Supreme Court, 1967)
Warth v. Seldin
422 U.S. 490 (Supreme Court, 1975)
Cannon v. University of Chicago
441 U.S. 677 (Supreme Court, 1979)
Babbitt v. United Farm Workers National Union
442 U.S. 289 (Supreme Court, 1979)
North Haven Board of Education v. Bell
456 U.S. 512 (Supreme Court, 1982)
City of Los Angeles v. Lyons
461 U.S. 95 (Supreme Court, 1983)
United States v. Morton
467 U.S. 822 (Supreme Court, 1984)
Allen v. Wright
468 U.S. 737 (Supreme Court, 1984)
Thomas v. Union Carbide Agricultural Products Co.
473 U.S. 568 (Supreme Court, 1985)
Bowen v. Massachusetts
487 U.S. 879 (Supreme Court, 1988)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Bennett v. Spear
520 U.S. 154 (Supreme Court, 1997)
Suitum v. Tahoe Regional Planning Agency
520 U.S. 725 (Supreme Court, 1997)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Massachusetts v. Environmental Protection Agency
549 U.S. 497 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
Neese v. Becerra, Counsel Stack Legal Research, https://law.counselstack.com/opinion/neese-v-becerra-txnd-2022.